9 - DM MedChem + Pharmacology Flashcards
Wut dis is
Meglitinides
insulin SECRETAGOGUES
- *Repaglinide / Nateglinide**
- less hypoGlycemia than sulfonylureas*
wut dis is
DPP-4 INHIBITORS
LASS
Linagliptin - Tradjenta
Alogliptin - Nesina
Sitagliptin - Januvia
Saxagliptin - Onglyza
Additives for
Short Acting Insulin
“humulin R / novolin R”
- *Soluble Crystalline ZINC insulin**
- nothing else*
Effect in <30 minutes
PEAK = 2-3 hours
Lasts = 5-8 Hours
SGLT-2 Inhibitors
MoA / AE
C-D-E-E- gliflozin
invokana = canagliflozin
Inhibit the sodium-glucose cotransporter 2 (SGLT2) in kidney
Blocking the reabsorption of glucose
allowing for the glucose to pass into the URINE
SGLT2 = main site of glucose reabsorption in the kidney
Sulfonylurea
SIDE EFFECTS + Drug Interactions
Glipizide + Glimepiride + Glyburide
hypoGlycemia
from too much GLUT4 taking in too much glucose
Metabolized by Liver -> excreted in kidney
Serum protein binding is HIGH
so it interacts with other HIGHLY PROTEIN BOUND DRUGS
Wut dis is?
BIGUANIDE
Metformin
BI = two of the same thang, litta N’s
Alpha Glucosidase Inhibitor
MoA
- Hydrolyses Oligosaccharides -> smaller Monosacharides
- which are absorbed in the GI TRACT
-
Delay Digestion of Ingested Carbs
- Reducing POSTPRANDIAL Blood Glucose conc.
-
Glucose levels then rise more SLOWLY
- LESS insulin response is required
-
Do not stimulate Insulin release
- so they do not result in hypoglycemia
wut dis is
Alpha-Glucosidase Inhibitors
ACARBOSE
Miglitol / Voglibose
Look like glucose ay ay
Meglitinides
MoA + SAR
Repaglinide + Nateglinide
Pancreatic Insulin Release = INSULIN SECRETAGOGUE
similar to Sulfonylureas
2 binding sites same as Sulfonylurea
+
1 Unique binding site
How is Insulin
Chemically Degradated?
NEUTRAL pH –> Deamination@ ASNB3
Acidic Conditions–>Deamination (rxn with water)
Oxidation of S-S Bridges –> aggregation / protein structure loss
INSULINASE = cleaves disulfide linkages in BLOOD
Rapid Acting Insulin Products
LISPRO
ASPART
GLULISINE
(LAG)
GLP-1 Receptor Agonists
MoA + Function
Liraglutide = Victoza / Dulaglutide = Trulicity
Exanatide / albiglutide
Incretin-Based Therapy
secreted in response to a meal, mostly by endocrine L-cells in small intestine
Stimulates first phase release of insulin from pancreatic beta cells
FA’s promote albumin binding & limits the DPP4 degradation
Glucagon Secretion / Gastric Emptying / Appetite
Alpha-Glucosidase Inhibitors
AE + Drug Interactions
Acarbose + Miglitol + Voglibase
Carbs are SITTING IN THE GUT –> GI Issues
Flatuelence + Diarrhea + Abdominal Pain
from appearance of undigested cabs in the colon
What FACTORS affect the
Onset / degree / duration of action
of Insulin?
Primary Protein Structure
ANY change in the AA residues @ N/C-terminus of B-chain
Insulin CRYSTAL type
soluble/amorphous / crystal / microcrystal
ZINC OR PROTAMINE
Site of Injection
abdomen / upper arm / thigh / buttock
Smoker / Temp / Exercise Etc.
DPP4 Inhibitors
MoA + SAR
L-A-S-S -gliptin
_*slows the inhibition* of GLP-1_
MORE INCRETIN FUNCTION
reduce / slow down
Glucagon Secretion / Gastric Emptying / Appetite